JR Rahn
Equibles does not estimate personal net worth.
Get an email with a short summary when Definium Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get DFTX alertsAbout JR Rahn
JR Rahn is recorded as CEO at Definium Therapeutics, Inc. (DFTX). The proxy statement of Definium Therapeutics, Inc. reports total compensation of $14,991,351 for JR Rahn in fiscal 2021, including a base salary of $213,333. Disclosed compensation is on record for 2 fiscal years. Definium Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Definium Therapeutics, Inc. includes Dr. Roger Crystal (CEO), Dr. Suzanne Bruhn (CEO), Robert Barrow (CEO) and 7 others.
Affiliation history
-
Current
Company network
Leadership on record at Definium Therapeutics, Inc.
- Dr. Roger Crystal CEO
- Dr. Suzanne Bruhn CEO
- Robert Barrow CEO
- Stephen Hurst CEO
- Carol A. Vallone Chairman
- Brandi L. Roberts CFO
- David Gryska CFO
- Roger Adsett COO, Board Member
- Carrie F. Liao Chief Accounting Officer
- Andreas Krebs Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Definium Therapeutics, Inc. (DFTX) | Former Chief Executive Officer | $213,333 | $14,991,351 |
| 2020 | Definium Therapeutics, Inc. (DFTX) | Former Chief Executive Officer | $266,667 | $1,234,493 |
Recent activity
No call appearances or filed executive changes recorded yet.